Natixis Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-24,665
| Closed | -$794K | – | 1585 |
|
|
2024
Q2 | $794K | Sell |
24,665
-3,284
| -12% | -$106K | ﹤0.01% | 1317 |
|
|
2024
Q1 | $1.09M | Buy |
27,949
+63
| +0.2% | +$2.45K | ﹤0.01% | 1192 |
|
|
2023
Q4 | $858K | Sell |
27,886
-26,473
| -49% | -$815K | ﹤0.01% | 1252 |
|
|
2023
Q3 | $1.22M | Buy |
54,359
+32,865
| +153% | +$735K | ﹤0.01% | 1125 |
|
|
2023
Q2 | $462K | Buy |
+21,494
| New | +$462K | ﹤0.01% | 1355 |
|
|
2020
Q4 | – | Sell |
-90,189
| Closed | -$1.88M | – | 1218 |
|
|
2020
Q3 | $1.88M | Buy |
90,189
+5,100
| +6% | +$106K | 0.01% | 809 |
|
|
2020
Q2 | $1.49M | Buy |
85,089
+10,751
| +14% | +$188K | 0.01% | 877 |
|
|
2020
Q1 | $1.21M | Buy |
+74,338
| New | +$1.21M | 0.01% | 856 |
|